173 related articles for article (PubMed ID: 35108241)
1. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients: An Updated Systematic Review and Meta-Analysis.
Elhusein AM; Fadlalmola HA
Gastroenterol Nurs; 2022 Jan-Feb 01; 45(1):11-20. PubMed ID: 35108241
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
Wang M; Xie X; Zhao S; Ma X; Wang Z; Zhang Y
Front Immunol; 2023; 14():1136343. PubMed ID: 37275867
[TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Halkjær SI; Lo B; Cold F; Højer Christensen A; Holster S; König J; Brummer RJ; Aroniadis OC; Lahtinen P; Holvoet T; Gluud LL; Petersen AM
World J Gastroenterol; 2023 May; 29(20):3185-3202. PubMed ID: 37346153
[TBL] [Abstract][Full Text] [Related]
4. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis.
Myneedu K; Deoker A; Schmulson MJ; Bashashati M
United European Gastroenterol J; 2019 Oct; 7(8):1033-1041. PubMed ID: 31662860
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
Xu D; Chen VL; Steiner CA; Berinstein JA; Eswaran S; Waljee AK; Higgins PDR; Owyang C
Am J Gastroenterol; 2019 Jul; 114(7):1043-1050. PubMed ID: 30908299
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplant delivered via invasive routes in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
Mohan BP; Loganathan P; Khan SR; Garg G; Muthusamy A; Ponnada S; Pasam RT; Chandan S; Tuteja A
Indian J Gastroenterol; 2023 Jun; 42(3):315-323. PubMed ID: 37247177
[TBL] [Abstract][Full Text] [Related]
8. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
Wu J; Lv L; Wang C
Front Cell Infect Microbiol; 2022; 12():827395. PubMed ID: 35295757
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Mazzawi T; El-Salhy M; Lied GA; Hausken T
Front Cell Infect Microbiol; 2021; 11():524851. PubMed ID: 34055657
[TBL] [Abstract][Full Text] [Related]
11. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
El-Salhy M; Casen C; Valeur J; Hausken T; Hatlebakk JG
World J Gastroenterol; 2021 May; 27(18):2219-2237. PubMed ID: 34025075
[TBL] [Abstract][Full Text] [Related]
12. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
13. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D.
Singh P; Alm EJ; Kelley JM; Cheng V; Smith M; Kassam Z; Nee J; Iturrino J; Lembo A
Gut Microbes; 2022; 14(1):2020067. PubMed ID: 35014601
[TBL] [Abstract][Full Text] [Related]
14. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y
Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452
[TBL] [Abstract][Full Text] [Related]
15. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
16. Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Jamshidi P; Farsi Y; Nariman Z; Hatamnejad MR; Mohammadzadeh B; Akbarialiabad H; Nasiri MJ; Sechi LA
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834010
[TBL] [Abstract][Full Text] [Related]
17. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
Huang HL; Chen HT; Luo QL; Xu HM; He J; Li YQ; Zhou YL; Yao F; Nie YQ; Zhou YJ
J Dig Dis; 2019 Aug; 20(8):401-408. PubMed ID: 31070838
[TBL] [Abstract][Full Text] [Related]
18. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
Körner E; Lorentz A
J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36882216
[TBL] [Abstract][Full Text] [Related]
19. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
[TBL] [Abstract][Full Text] [Related]
20. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.
Browne PD; Cold F; Petersen AM; Halkjær SI; Christensen AH; Günther S; Hestbjerg Hansen L
Gut Microbes; 2021; 13(1):1-16. PubMed ID: 34074214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
